Citation & Authors
CNS Drugs. 2026;40(1):111-121.
ABSTRACT · RESEARCH SUMMARY
Research summary
This weighted Taiwanese National Health Insurance cohort compared antihypertensive drugs after a first ischemic stroke. Compared with other antihypertensives, ACEIs/ARBs and CCBs were associated with approximately 14% and 15% lower risks of recurrent stroke, respectively, but CCBs were associated with more acute myocardial infarctions. ARBs were also associated with lower risks of recurrent stroke and stroke-related death than ACEIs, providing observational evidence relevant to treatment selection.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
